News for BCAN Stock

Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) BYND Cannasoft Entering Production Agreements for its EZ-G Device Aegis Capital Corp. Acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US Israel's Finance Ministry Increases Israel Innovation Authority's High-Tech Sector Fast-Track Fund to $100 Million During Wartime Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Second Quarter 2023 Financial Results BYND Cannasoft CEO Delivers Update Amidst Promising Milestones Israeli Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023 Aegis Capital Corp. Acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) BYND Cannasoft Closes US$2.6 Million Underwritten Public Offering BYND Cannasoft Announces Pricing of US$2.6 Million Underwritten Public Offering BYND Cannasoft Announces Proposed Underwritten Public Offering BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization U.S. Patent filed by BYND Cannasoft to Expand its Artificial Intelligence and Machine Learning Algorithm to a Male Treatment Device The Patent Cooperation Treaty (PCT) Provides Positive Opinion on BYND Cannasoft’s AI-Based Female Treatment Device Multinational BYND Cannsoft to Utilize Israeli License for Its EZ-G Smart Cartridges Using Artificial intelligence (AI) Software to Individualize Each Dose U.S. Patent Filed for AI Based Technology as BYND Cannasoft Enters the Multibillion-Dollar Sextech Industry Israeli Cannabis Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device CEO’s Letter to Shareholders $62 Billion Potential Sex Toy Market Could be Disrupted by Israeli Cannabis Technology Company BYND Cannasoft Enterprises’ PCT Patent Application Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom $10.97 Billion Potential Global Condom Market Could Be a Key Driver of Growth for Israeli Cannabis Technology Company BYND Cannasoft Enterprises Israeli Technology Company BYND Cannasoft Enterprises Inc. Announces Contract for Its Benefit CRM Cloud-Based Software as a Service CRM Platform 494% Increase in Assets to US$33 million Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Poised for Growth Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Third Quarter 2022 Financial Results Israeli Cannabis Technology Company BYND Cannasoft Enterprises Provides Update on International Patent Application Process for its Revolutionary EZ-G Device Tel Aviv Listed Together Pharma’s Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ Subsidiary Sign First Commercial Agreement for Medical Cannabis Products BYND Cannasoft Enterprises CEO Discusses Marijuana Reform and Corporate Advancements in Audio Interview with SmallCapVoice.com Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. and Matrix Medika to Explore Further (FDA) Development of the EZ-G Device Israel’s Ministry of Health, through the Medical Cannabis Unit, granted BYND Cannasoft Enterprises Inc.’s Subsidiary, Cannasoft an Initial Approval to Engage in Medical Cannabis Without Direct Contact with the Substance Bynd Cannasoft Enterprises Inc. Announces $649,500 Non-Brokered Private Placement Financing BYND Cannasoft Enterprises Inc. Launches Beta Test for Managing Farms CRM Platform at Israel’s Weizmann Institute of Science Israeli Technology Company BYND Cannasoft Closes Acquisition of Zigi Carmel Investments Ltd. Valued at US $28 Million BYND Cannasoft Enterprises CEO Discusses Latest Developments, Key Objectives in Audio Interview with SmallCapVoice.com REPEAT -- BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives & Investments Ltd. In a Share Swap Agreement Valued at US $28 Million BYND Cannasoft Enterprises Inc. Signs Agreement for the Acquisition of Israeli-Based Zigi Carmel Initiatives & Investments Ltd. In a Share Swap Agreement Valued at US $28 Million